Vikram R. Paralkar
- Molecular Biology
- Cancer Research top 5%
- Hematology top 10%
- Oncology
- Immunology
- Co-authors
- Mitchell J. WeissJing LuanYu YaoRoss C. HardisonAndrew V. KossenkovPeng HuangGerd A. BlobelJames Davies
- Topics
- Acute Myeloid Leukemia Research (10 papers)RNA modifications and cancer (10 papers)Cancer-related molecular mechanisms research (7 papers)
- Partner nations
- United StatesUnited KingdomNew Zealand
In The Last Decade
Vikram R. Paralkar
24 papers receiving 616 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 454
- Cancer Research 322
- Hematology 106
- Oncology 56
- Immunology 50
Countries citing papers authored by Vikram R. Paralkar
This map shows the geographic impact of Vikram R. Paralkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram R. Paralkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram R. Paralkar more than expected).
Fields of papers citing papers by Vikram R. Paralkar
This network shows the impact of papers produced by Vikram R. Paralkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram R. Paralkar. The network helps show where Vikram R. Paralkar may publish in the future.
Co-authorship network of co-authors of Vikram R. Paralkar
This figure shows the co-authorship network connecting the top 25 collaborators of Vikram R. Paralkar. A scholar is included among the top collaborators of Vikram R. Paralkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram R. Paralkar. Vikram R. Paralkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 13 | |
| 5 | 3 | |
| 6 | 53 | |
| 7 | 12 | |
| 8 | 11 | |
| 9 | 1 | |
| 10 | 42 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 36 | |
| 14 | 184 | |
| 15 | 133 | |
| 16 | 1 | |
| 17 | 21 | |
| 18 | 31 | |
| 19 | 3 | |
| 20 | 7 |
About Vikram R. Paralkar
Vikram R. Paralkar is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 24 papers that have together received 619 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (322 citations), Hematology (106 citations) and Molecular Biology (454 citations). Vikram R. Paralkar has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Mitchell J. Weiss, Jing Luan, Yu Yao, Ross C. Hardison, Andrew V. Kossenkov, Peng Huang, Gerd A. Blobel, James Davies, Jim R. Hughes and Maxim Pimkin. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.